Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been ...

The antiviral drug valaciclovir (Valtrex), given prophylactically, kept patients with systemic lupus erythematosus (SLE) ...

Columnist Candace Semien praises the community's ability to survive and thrive without guilt while living with lupus.

Barclays PLC purchased a new position in shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the ...

ALM-223 is under development for the treatment of systemic lupus erythematosus (SLE) and atopic dermatitis (AD). It is administered through subcutaneous route in the form of liquid. It is a fusion ...

Belantamab mafodotin is under clinical development by GSK and currently in Phase I for Systemic Lupus Erythematosus.

A history of infertility without fertility treatment was associated with a higher future risk of SARD, independent of co-existing adverse pregnancy outcomes.

Patients with SLE have a higher prevalence of primary headaches vs those with RA or pSS, but similar percentages were found ...

The increased risks for arterial thrombotic events (ATE), venous thromboembolism (VTE), and all-cause mortality known to be ...

The intricate link between endocrine disorders and cancer development has drawn significant interest, revealing how conditions like insulin resistance and ...

Nkarta focuses on autoimmune diseases, with $402.5M in cash. Read why NKTX stock, currently undervalued, offers multiple ...

Caribou Biosciences, Inc. data from phase 1 ANTLER study is expected in 1H 2025. Click here to find out why I'm neutral on ...